|
AMINOSYN-PF
|
6505-01-262-8724
|
Amino Acid Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
AMINOSYN-PF 7%
|
6505-01-262-8724
|
Amino Acid Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
1616-03
|
6505-01-262-8724
|
Amino Acid Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-1616-03
|
6505-01-262-8724
|
Amino Acid Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-1616-03
|
6505-01-262-8724
|
Amino Acid Injection |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00074-1616-03
|
6505-01-262-8724
|
Amino Acid Injection |
Abbott Laboratories
|
|
Quote
|
|
ESTRADERM
|
6505-01-263-0663
|
Estradiol Transdermal System |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-2320-62
|
6505-01-263-0663
|
Estradiol Transdermal System |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-2320-62
|
6505-01-263-0663
|
Estradiol Transdermal System |
Novartis Pharmaceuticals Corporation
|
|
Quote
|
|
MEFOXIN
|
6505-01-263-0730
|
Usp Cefoxitin For Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC00006-3388-67
|
6505-01-263-0730
|
Usp Cefoxitin For Injection |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
1308-11
|
6505-01-263-2593
|
Usp Mineral Oil |
Stryker Corporation
|
|
Quote
|
|
1308-011-000
|
6505-01-263-2593
|
Usp Mineral Oil |
Stryker Corporation
|
|
Quote
|
|
NDC00536-3223-01
|
6505-01-263-3390
|
Calcium Citrate Tablets |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
MICRONASE
|
6505-01-263-4532
|
Usp Glyburide Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
MICRONASE TABLETS
|
6505-01-263-4532
|
Usp Glyburide Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00009-0171-12
|
6505-01-263-4532
|
Usp Glyburide Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC54569-3831-02
|
6505-01-263-4532
|
Usp Glyburide Tablets |
Allscripts Healthcare Solutions Inc
|
|
Quote
|
|
NDC59762-3727-03
|
6505-01-263-4533
|
Usp Glyburide Tablets |
Greenstone Ltd
|
|
Quote
|
|
NDC54569-8601-03
|
6505-01-263-4533
|
Usp Glyburide Tablets |
Merck Sharp & Dohme Corp.
|
|
Quote
|
|
NDC57866-6409-03
|
6505-01-263-4533
|
Usp Glyburide Tablets |
Vibranta Inc.
|
|
Quote
|
|
NDC00009-0171-13
|
6505-01-263-4533
|
Usp Glyburide Tablets |
Pharmacia & Upjohn Company
|
|
Quote
|
|
NDC00168-0062-02
|
6505-01-263-4534
|
Usp Zinc Oxide Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00168-0062-02
|
6505-01-263-4534
|
Usp Zinc Oxide Ointment |
Fougera Pharmaceuticals Inc.
|
|
Quote
|
|
5M7235
|
6505-01-263-7880
|
Concentrat Hemodialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00029-6074-47
|
6505-01-264-2366
|
Amoxicillin And Clavulanate Pota |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00029-6074-47
|
6505-01-264-2366
|
Amoxicillin And Clavulanate Pota |
Veterans Health
|
|
Quote
|
|
NDC00591-2520-01
|
6505-01-264-4453
|
Usp Chlorzoxazone Tablets |
Watson Pharmaceuticals Inc.
|
|
Quote
|
|
OMNIPAQUE 300 INJECTION
|
6505-01-264-4454
|
Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
NDC/0024-1413-30
|
6505-01-264-4454
|
Iohexol Injection |
Sanofi-synthelabo Inc
|
|
Quote
|
|
ATIVAN REDIPAK
|
6505-01-264-4627
|
Usp Lorazepam Tablets |
American Home Products Corp
|
|
Quote
|
|
NDC00008-0081-04
|
6505-01-264-4627
|
Usp Lorazepam Tablets |
American Home Products Corp
|
|
Quote
|
|
CAPOTEN
|
6505-01-264-5553
|
Usp Captopril Tablets |
Squibb E R and Sons Inc
|
|
Quote
|
|
CAPOTEN TABLETS
|
6505-01-264-5553
|
Usp Captopril Tablets |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00003-0450-51
|
6505-01-264-5553
|
Usp Captopril Tablets |
Par Pharmaceutical, Inc.
|
|
Quote
|
|
NDC00003-0450-51
|
6505-01-264-5553
|
Usp Captopril Tablets |
Squibb E R and Sons Inc
|
|
Quote
|
|
NDC00186-1014-13
|
6505-01-264-9828
|
Dopamine Hydrochloride Injection |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
13505
|
6505-01-264-9828
|
Dopamine Hydrochloride Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00469-1350-20
|
6505-01-264-9828
|
Dopamine Hydrochloride Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00186-1014-13
|
6505-01-264-9828
|
Dopamine Hydrochloride Injection |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
13505
|
6505-01-264-9828
|
Dopamine Hydrochloride Injection |
Lyphomed Inc
|
|
Quote
|
|
NDC00469-1350-20
|
6505-01-264-9828
|
Dopamine Hydrochloride Injection |
Lyphomed Inc
|
|
Quote
|
|
DIDRONEL
|
6505-01-265-0005
|
Etidronate Disodium Injection |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC58063-0457-01
|
6505-01-265-0005
|
Etidronate Disodium Injection |
Mgi Pharma Inc
|
|
Quote
|
|
NDC00149-0457-01
|
6505-01-265-0005
|
Etidronate Disodium Injection |
Procter & Gamble Pharmaceuticals
|
|
Quote
|
|
NDC00409-2266-05
|
6505-01-265-0009
|
Alfentanil Hydrochloride Injecti |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-2266-05
|
6505-01-265-0009
|
Alfentanil Hydrochloride Injecti |
Hospira, Inc.
|
|
Quote
|
|
NDC00409-2266-05
|
6505-01-265-0009
|
Alfentanil Hydrochloride Injecti |
Hospira, Inc.
|
|
Quote
|
|
5250
|
6505-01-265-0052
|
Usp Calcium Carbonate Tablets |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00054-8120-25
|
6505-01-265-0052
|
Usp Calcium Carbonate Tablets |
Boehringer Ingelheim Roxane, Inc.
|
|
Quote
|
|
NDC00615-0871-13
|
6505-01-265-0052
|
Usp Calcium Carbonate Tablets |
Medical Technologies System Inc
|
|
Quote
|
|
144840
|
6505-01-265-0052
|
Usp Calcium Carbonate Tablets |
Major Crown Inc
|
|
Quote
|
|
NDC00904-1883-61
|
6505-01-265-0052
|
Usp Calcium Carbonate Tablets |
Major Crown Inc
|
|
Quote
|
|
NDC00270-1410-30
|
6505-01-265-0055
|
Diatrizoate Meglumine Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-1410-30
|
6505-01-265-0055
|
Diatrizoate Meglumine Injection |
Squibb E R and Sons Inc
|
|
Quote
|
|
CYSTOGRAFIN DILUTE
|
6505-01-265-0055
|
Diatrizoate Meglumine Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-1410-30
|
6505-01-265-0055
|
Diatrizoate Meglumine Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
CYSTOGRAFIN DILUTE
|
6505-01-265-0055
|
Diatrizoate Meglumine Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
NDC00270-1410-30
|
6505-01-265-0055
|
Diatrizoate Meglumine Injection |
Bracco Diagnostics Inc
|
|
Quote
|
|
A91B108
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
Department of the Army
|
|
Quote
|
|
NDC63323-0064-20
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00469-6400-40
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
Lyphomed Inc
|
|
Quote
|
|
A91B108
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
Department of the Army
|
|
Quote
|
|
NDC63323-0064-20
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00469-6400-40
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
Lyphomed Inc
|
|
Quote
|
|
A91B108
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
Department of the Army
|
|
Quote
|
|
NDC63323-0064-20
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC00469-6400-40
|
6505-01-265-0056
|
Usp Magnesium Sulfate Injection |
Lyphomed Inc
|
|
Quote
|
|
CLINIDINE
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
4444
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
NDC19154-4444-01
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
4444
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
CLINIDINE
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
NDC19154-4444-01
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
4444
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
CLINIDINE
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
NDC19154-4444-01
|
6505-01-265-0059
|
Povidone-iodine Topical Solution |
The Clinipad Corp
|
|
Quote
|
|
87-5-26-218
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Naval Medical Material Support
|
|
Quote
|
|
000227
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
FML FORTE
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
NDC11980-0228-05
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
87-5-26-218
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Naval Medical Material Support
|
|
Quote
|
|
000227
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
FML FORTE
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
NDC11980-0228-05
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
87-5-26-218
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Naval Medical Material Support
|
|
Quote
|
|
000227
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
FML FORTE
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
NDC11980-0228-05
|
6505-01-265-0061
|
Fluorometholone Ophthalmic Suspe |
Allergan Inc
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
VANCOCIN
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
VANCOCIN CAPSULES
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC66593-3126-02
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Viropharma Incorporated
|
|
Quote
|
|
NDC00002-3126-42
|
6505-01-265-1302
|
Vancomycin Hydrochloride Capsule |
Eli Lilly and Company
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
3808
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
NDC00615-0323-13
|
6505-01-265-1327
|
Usp Quinine Sulfate Capsules |
Medical Technologies System Inc
|
|
Quote
|
|
CIN-QUIN TABLETS
|
6505-01-265-2570
|
Usp Quinidine Sulfate Tablets |
Solvay Pharmaceuticals Inc.
|
|
Quote
|
|
NDC00032-4024-01
|
6505-01-265-2570
|
Usp Quinidine Sulfate Tablets |
Solvay Pharmaceuticals Inc.
|
|
Quote
|
